Results 71 to 80 of about 4,882 (132)

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease. [PDF]

Nat Commun, 2021
Schmidt AF, Hunt NB, Gordillo-Marañón M, Charoen P, Drenos F, Kivimaki M, Lawlor DA, Giambartolomei C, Papacosta O, Chaturvedi N, Bis JC, O'Donnell CJ, Wannamethee G, Wong A, Price JF, Hughes AD, Gaunt TR, Franceschini N, Mook-Kanamori DO, Zwierzyna M, Sofat R, Hingorani AD, Finan C.   +22 more
europepmc   +1 more source

CETP Inhibition: Past Failures and Future Hopes

Clinical Medicine Insights: Cardiology, 2016
The atheroprotective role of high-density lipoprotein cholesterol (HDL-C) in cardiovascular disease has been unequivocally established, and epidemiological data have clearly demonstrated a strong inverse relationship between HDL-C levels and the risk of ...
Constantine E. Kosmas, Eddy Dejesus, Digna Rosario, Timothy J. Vittorio   +3 more
doaj   +1 more source

The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction. [PDF]

Biomolecules, 2021
Wanschel ACBA, Guizoni DM, Lorza-Gil E, Salerno AG, Paiva AA, Dorighello GG, Davel AP, Balkan W, Hare JM, Oliveira HCF.   +9 more
europepmc   +1 more source

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

Vascular Health and Risk Management, 2012
Marta A Miyares, Kyle DavisPharmacy Department, Jackson Memorial Hospital, Miami, FL, USAAbstract: Cardiovascular disease (CVD) is responsible for significant morbidity and mortality within the United States and worldwide.
Miyares MA, Davis K
doaj  

Comparing the effect profile of cholesteryl ester transfer protein (CETP) in individuals of East Asian and European ancestries

, 2023
Dunca D, Chopade S, Gordillo-Maranon M, Hingorani A, Kuchenbaecker K, Finan C, Schmidt A.   +6 more
europepmc   +1 more source

Comparative effectiveness of cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis and network meta-regression. [PDF]

Medicine (Baltimore)
Khalil I, Islam MR, Promi SA, Joy AD, Sayed MA, Acharjee D, Al-Shammari AS, Rahman MT, Abrar S, Bin Jamil TS, Taseen M, Biswas S, Mifty SK, Al-Badri SG, Debnath A, Hossain MI, Akter MM.   +16 more
europepmc   +1 more source

Comparative Effectiveness of Cholesteryl Ester Transfer Protein (CETP) Inhibitors on Lipid Profiles in Adults With Hyperlipidemia: A Comprehensive Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials. [PDF]

Clin Cardiol
Khalil I, Islam MR, Promi SA, Joy AD, Sayed MA, Acharjee D, Al-Shammari AS, Abrar S, Jamil TB, Taseen M, Biswas S, Mifty SK, Al-Badri SG, Debnath A, Hossain MI, Akter M.   +15 more
europepmc   +1 more source

Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case. [PDF]

Pharmacol Res Perspect, 2019
Johns DG, Wang SP, Rosa R, Hubert J, Xu S, Chen Y, Bateman T, Blaustein RO.   +7 more
europepmc   +1 more source

Correction: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysis. [PDF]

Alzheimers Res Ther
Schmidt AF, Davidson MH, Ditmarsch M, Kastelein JJ, Finan C.   +4 more
europepmc   +1 more source

Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis. [PDF]

Alzheimers Res Ther
Schmidt AF, Davidson MH, Ditmarsch M, Kastelein JJ, Finan C.   +4 more
europepmc   +1 more source